Logo

Newly Public Rosetta Genomics Says Q4 R&D Rises 30 Percent; No Revenue Yet

Mar 27, 2007
NEW YORK (GenomeWeb News) — Rosetta Genomics today released its first earnings statement as a new public company, saying it generated no revenues in the fourth quarter, R&D spending increased 30 percentl, and net losses increased 16 percent.
 
R&D spending for the three months ended Dec. 31, 2006, increased to $1.3 million from $1 million in the year-ago period.
 
The company said net loss increased to $2.1 million from $1.8 million in the fourth quarter of 2005.
 
Rosetta, which went public last month, said it had around $5.2 million in cash and equivalents as of Dec. 31.
 
The company said it is collaborating with Isis pharmaceuticals for a micro-RNA-based therapeutic for liver cancer, and said it has agreements in place with Max-Planck-Innovation, the Rockefeller University and Johns Hopkins University.

Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.